{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T00:37:30Z","timestamp":1793752650496,"version":"4.6.1"},"reference-count":43,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2008,7,1]],"date-time":"2008-07-01T00:00:00Z","timestamp":1214870400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,7,1]],"date-time":"2008-07-01T00:00:00Z","timestamp":1214870400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2008,7,1]],"date-time":"2008-07-01T00:00:00Z","timestamp":1214870400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["international-journal-of-gynecological-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Gynecological Cancer"],"published-print":{"date-parts":[[2008,7]]},"DOI":"10.1136\/ijgc-00009577-200807000-00003","type":"journal-article","created":{"date-parts":[[2024,10,21]],"date-time":"2024-10-21T05:14:58Z","timestamp":1729487698000},"page":"615-620","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":101,"title":["Analysis of the pattern of hypersensitivity reactions in patients receiving carboplatin retreatment for recurrent ovarian cancer"],"prefix":"10.1016","volume":"18","author":[{"given":"A.","family":"Gadducci","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Tana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Teti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Zanca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Fanucchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.R.","family":"Genazzani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1136\/ijgc-00009577-200807000-00003_bb0005","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/0959-8049(94)90489-8","article-title":"Hypersensitivity reactions to carboplatin given to patients with relapsed ovarian carcinoma","volume":"30A","author":"Morgan","year":"1994","journal-title":"Eur J Cancer"},{"key":"10.1136\/ijgc-00009577-200807000-00003_bb0010","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1200\/JCO.1999.17.4.1141","article-title":"Clinical features of hypersensitivity reactions to carboplatin","volume":"17","author":"Markman","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1136\/ijgc-00009577-200807000-00003_bb0015","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1200\/JCO.2000.18.1.102","article-title":"Paclitaxel-associated hypersensitivity reactions: experience of the gynecologic oncology program of the Cleveland Clinic Cancer Center","volume":"18","author":"Markman","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1136\/ijgc-00009577-200807000-00003_bb0020","doi-asserted-by":"crossref","first-page":"767","DOI":"10.2165\/00002018-200124100-00005","article-title":"Prevention and management of antineoplastic-induced hypersensitivity reactions","volume":"24","author":"Zanotti","year":"2001","journal-title":"Drug Saf"},{"key":"10.1136\/ijgc-00009577-200807000-00003_bb0025","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1159\/000055363","article-title":"Hypersensitivity reactions to carboplatin administration are common but not always severe: a 10-year experience","volume":"61","author":"Polyzos","year":"2001","journal-title":"Oncology"},{"key":"10.1136\/ijgc-00009577-200807000-00003_bb0030","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1006\/gyno.2001.6513","article-title":"Hypersensitivity reactions to carboplatin","volume":"84","author":"Markman","year":"2002","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-00009577-200807000-00003_bb0035","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1385\/CRIAI:24:3:253","article-title":"Hypersensitivity reactions to chemotherapeutic drugs","volume":"24","author":"Sheperd","year":"2003","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1136\/ijgc-00009577-200807000-00003_bb0040","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1136\/ijgc-00009577-200501000-00003","article-title":"Carboplatin hypersensitivity","volume":"15","author":"Sliesoraitis","year":"2005","journal-title":"Int J Gynecol Cancer"},{"key":"10.1136\/ijgc-00009577-200807000-00003_bb0045","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.ygyno.2006.03.007","article-title":"Atypical presentations of carboplatin hypersensitivity reactions: characterization and management in patients with gynecologic malignancies","volume":"103","author":"McAlpine","year":"2006","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-00009577-200807000-00003_bb0050","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S1040-8428(99)00036-0","article-title":"Up date in the management of advanced ovarian carcinoma","volume":"32","author":"Conte","year":"1999","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1136\/ijgc-00009577-200807000-00003_bb0055","doi-asserted-by":"crossref","first-page":"3084","DOI":"10.1200\/JCO.2000.18.17.3084","article-title":"Exploratory phase III study of paclitaxel and cisplatin versus paclitaxel and carboplatin in advanced ovarian cancer","volume":"18","author":"Neijt","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1136\/ijgc-00009577-200807000-00003_bb0060","doi-asserted-by":"crossref","first-page":"3194","DOI":"10.1200\/JCO.2003.02.153","article-title":"Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: a Gynecologic Oncology Group Study","volume":"21","author":"Ozols","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1136\/ijgc-00009577-200807000-00003_bb0065","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1093\/jnci\/djg036","article-title":"A randomized clinical trial of cisplatin\/paclitaxel versus carboplatin\/paclitaxel as first-line treatment of ovarian cancer","volume":"95","author":"du Bois","year":"2003","journal-title":"J Natl Cancer Inst"},{"key":"10.1136\/ijgc-00009577-200807000-00003_bb0070","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1136\/ijgc-00009577-200409000-00001","article-title":"Remaining controversies in the upfront management of advanced ovarian cancer","volume":"14","author":"Mano","year":"2004","journal-title":"Int J Gynecol Cancer"},{"key":"10.1136\/ijgc-00009577-200807000-00003_bb0075","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1016\/S0140-6736(03)13718-X","article-title":"Paclitaxel plus platinum- based chemotherapy versus conventional platinum-based chemotherapy in women with relapsed ovarian cancer: the ICON4\/AGO-OVAR-2.2 trial","volume":"361","author":"Parmar","year":"2003","journal-title":"Lancet"},{"key":"10.1136\/ijgc-00009577-200807000-00003_bb0080","doi-asserted-by":"crossref","first-page":"4699","DOI":"10.1200\/JCO.2006.06.0913","article-title":"Gemcitabine plus carboplatin compared with carboplatin in patients with platinum-sensitive recurrent ovarian cancer: an intergroup trial of the AGO-OVAR, the NCIC CTG, and the EORTC GCG","volume":"24","author":"Pfisterer","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1136\/ijgc-00009577-200807000-00003_bb0085","article-title":"Management of platinum-sensitive recurrent ovarian cancer","volume":"33(Suppl.):S12\u20136","author":"Pfisterer","year":"2006","journal-title":"Semin Oncol"},{"key":"10.1136\/ijgc-00009577-200807000-00003_bb0090","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.ygyno.2004.08.002","article-title":"Carboplatin hypersensitivity: a 6-h 12-step protocol effective in 35 desensitizations in patients with gynecological malignancies and mast cell\/IgE-mediated reactions","volume":"95","author":"Lee","year":"2004","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-00009577-200807000-00003_bb0095","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1016\/0959-8049(93)90093-U","article-title":"Carboplatin hypersensitivity: case reports and review of the literature","volume":"29A","author":"Tonkin","year":"1993","journal-title":"Eur J Cancer"},{"key":"10.1136\/ijgc-00009577-200807000-00003_bb0100","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1002\/1097-0142(19940415)73:8<2218::AID-CNCR2820730830>3.0.CO;2-1","article-title":"Hypersensitivity reactions to carboplatin. Report of two patients, review of the literature, and discussion of diagnostic procedures and management","volume":"73","author":"Weidmann","year":"1994","journal-title":"Cancer"},{"key":"10.1136\/ijgc-00009577-200807000-00003_bb0105","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.ygyno.2006.04.002","article-title":"Evaluation of the incidence of carboplatin hypersensitivity reactions in cancer patients","volume":"103","author":"Navo","year":"2006","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-00009577-200807000-00003_bb0110","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.critrevonc.2005.03.003","article-title":"Consolidation and maintenance treatments for patients with advanced epithelial ovarian cancer in complete response after first-line chemotherapy: a review of the literature","volume":"55","author":"Gadducci","year":"2005","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1136\/ijgc-00009577-200807000-00003_bb0115","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1093\/oxfordjournals.annonc.a058160","article-title":"Allergic reactions to carboplatin","volume":"3","author":"Hendrick","year":"1992","journal-title":"Ann Oncol"},{"key":"10.1136\/ijgc-00009577-200807000-00003_bb0120","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1136\/ijgc-00009577-200509000-00011","article-title":"Cisplatinum rechallenge in relapsed ovarian cancer patients with platinum reinduction therapy and carboplatin hypersensitivity","volume":"15","author":"Kandel","year":"2005","journal-title":"Int J Gynecol Cancer"},{"key":"10.1136\/ijgc-00009577-200807000-00003_bb0125","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1136\/ijgc-00009577-200503000-00006","article-title":"Carboplatin hypersensitivity induced by low-dose paclitaxel\/carboplatin in multiple platinum-treated patients with recurrent ovarian cancer","volume":"15","author":"Watanabe","year":"2005","journal-title":"Int J Gynecol Cancer"},{"key":"10.1136\/ijgc-00009577-200807000-00003_bb0130","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1253\/jcj.60.185","article-title":"Vasospastic angina after chemotherapy with carboplatin and etoposide in a patient with lung cancer","volume":"60","author":"Yano","year":"1996","journal-title":"Jpn Circ J"},{"key":"10.1136\/ijgc-00009577-200807000-00003_bb0135","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s00280-002-0518-3","article-title":"Carboplatin hypersensitivity presenting as coronary vasospasm\u2014a case report","volume":"50","author":"Chasen","year":"2002","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1136\/ijgc-00009577-200807000-00003_bb0140","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.ygyno.2006.10.047","article-title":"Does the platinum-free interval predict the incidence or severity of hypersensitivity reactions to carboplatin? The experience from Women and Infants Hospital","volume":"105","author":"Schwartz","year":"2007","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-00009577-200807000-00003_bb0145","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1006\/gyno.1994.1098","article-title":"Death from anaphylaxis to cisplatin: a case report","volume":"53","author":"Zweizig","year":"1994","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-00009577-200807000-00003_bb0150","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1177\/030089169908500418","article-title":"Hypersensitivity reaction to carboplatin during treatment for ovarian cancer: successful resolution by replacement with cis- platin","volume":"85","author":"Shukunami","year":"1999","journal-title":"Tumori"},{"key":"10.1136\/ijgc-00009577-200807000-00003_bb0155","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1200\/JCO.2001.19.7.1901","article-title":"Combination chemotherapy with carboplatin and docetaxel in the treatment of cancers of the ovary and fallopian tube and primary carcinoma of the peritoneum","volume":"19","author":"Markman","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1136\/ijgc-00009577-200807000-00003_bb0160","first-page":"335","article-title":"Hypersensitivity reaction to carboplatin. Successful resolution by replacement with cisplatin","volume":"23","author":"Porzio","year":"2002","journal-title":"Eur J Gynaecol Oncol"},{"key":"10.1136\/ijgc-00009577-200807000-00003_bb0165","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1006\/gyno.2001.6519","article-title":"Analysis of patients with epithelial ovarian cancer or fallopian tube carcinoma retreated with cisplatin after development of a carboplatin allergy","volume":"84","author":"Dizon","year":"2002","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-00009577-200807000-00003_bb0170","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/S0090-8258(03)00066-0","article-title":"Carboplatin hypersensitivity reactions: re-treatment with cisplatin desensitisation","volume":"89","author":"Jones","year":"2003","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-00009577-200807000-00003_bb0175","first-page":"311","article-title":"Cisplatin may be a valid alternative approach in ovarian carcinoma with carboplatin hypersensitivity","volume":"89","author":"Libra","year":"2003","journal-title":"Report of three cases. Tumori"},{"key":"10.1136\/ijgc-00009577-200807000-00003_bb0180","first-page":"353","article-title":"Replacement of carboplatin by oxaliplatin may be one solution for patients treated for ovarian carcinoma who are hypersensitive to carboplatin","volume":"20","author":"Gutierrez","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1136\/ijgc-00009577-200807000-00003_bb0185","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1200\/JCO.2002.20.4.1146","article-title":"Hypersensitivity reactions to oxaliplatin: cross-reactivity to carboplatin and the introduction of a desensitization schedule","volume":"20","author":"Meyer","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1136\/ijgc-00009577-200807000-00003_bb0190","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/S0091-6749(96)70134-3","article-title":"A modified, prolonged desensitization protocol in carboplatin allergy","volume":"98","author":"Goldberg","year":"1996","journal-title":"J Allergy Clin Immunol"},{"key":"10.1136\/ijgc-00009577-200807000-00003_bb0195","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1006\/gyno.2001.6331","article-title":"Hypersensitivity reactions and the utility of oral and intravenous desensitization in patients with gynecologic malignancies","volume":"82","author":"Robinson","year":"2001","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-00009577-200807000-00003_bb0200","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S0090-8258(03)00178-1","article-title":"Successful administration of carboplatin in patients with clinically documented carboplatin hypersensitivity","volume":"89","author":"Rose","year":"2003","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-00009577-200807000-00003_bb0205","doi-asserted-by":"crossref","first-page":"3126","DOI":"10.1200\/JCO.2001.19.12.3126","article-title":"Carboplatin skin testing: a skin-testing protocol for predicting hypersensitivity to carboplatin chemotherapy","volume":"19","author":"Zanotti","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1136\/ijgc-00009577-200807000-00003_bb0210","doi-asserted-by":"crossref","first-page":"4611","DOI":"10.1200\/JCO.2003.05.539","article-title":"Expanded experience with an intradermal skin test to predict for the presence or absence of carboplatin hypersensitivity","volume":"21","author":"Markman","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1136\/ijgc-00009577-200807000-00003_bb0215","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.jaci.2006.11.640","article-title":"Diagnostic and predictive value of skin testing in platinum salt hypersensitivity","volume":"119","author":"Leguy-Seguin","year":"2007","journal-title":"J Allergy Clin Immunol"}],"container-title":["International Journal of Gynecological Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24034996?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24034996?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ijgc-00009577-200807000-00003","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T01:12:03Z","timestamp":1753233123000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1048891X24034996"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,7]]},"references-count":43,"aliases":["10.1111\/j.1525-1438.2007.01063.x","10.1111\/j.1525-1438.2007.01063.x"],"journal-issue":{"issue":"4","published-print":{"date-parts":[[2008,7]]}},"alternative-id":["S1048891X24034996"],"URL":"https:\/\/doi.org\/10.1136\/ijgc-00009577-200807000-00003","relation":{},"ISSN":["1048-891X"],"issn-type":[{"value":"1048-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2008,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Analysis of the pattern of hypersensitivity reactions in patients receiving carboplatin retreatment for recurrent ovarian cancer","name":"articletitle","label":"Article Title"},{"value":"International Journal of Gynecological Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ijgc-00009577-200807000-00003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008, IGCS and ESGO","name":"copyright","label":"Copyright"}]}}